2017 INDEPENDENT SUPPORTED SYMPOSIA
The 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO) will feature multiple Independent Supported Symposia (ISS) Sessions. Lunch-time ISS sessions will be held on Friday and Saturday and an evening ISS session will be held on Friday evening.
FRIDAY, NOVEMBER 17, 2017
LUNCH-TIME ISS SESSION: 12:15PM – 1:15PM
Incorporating New Strategies: Current and Future Directions in Glioblastoma Management
Supported by a grant from Novocure
Location: Yerba Buena Salons 13-15
Chair: Maciej Mrugala, MD, PhD, MPH - Mayo Clinic
Speakers:
Maciej Mrugala, MD, PhD, MPH - Mayo Clinic
Rimas Lukas, MD - Northwestern University
David Reardon, MD- Dana-Farber Cancer Institute
Presentations:
A new look at local therapy in GBM
Rimas Lukas
The impact of immunotherapy in GBM: Now and in the near term
David Reardon
Clinical vignettes revisited and prIME Points™
Maciej Mrugala
For more information and to register, please visit http://www.primeoncology.org/live-education/solid-tumor/sno-gbm-2017/
EVENING ISS SESSION: 5:30PM – 7:30PM
NOVALIS CIRCLE SYMPOSIUM - Advanced Imaging and Stereotactic Technologies to Enhance Immunotherapy for Brain Tumors
Supported by Brainlab
Location: Yerba Buena Salons 13 - 15
Speakers:
Michael Lim, MD - Johns Hopkins Medicine
Orin Bloch, MD - Northwestern Memorial Hospital
Gavin Dunn, MD, PhD – Washington University
Andrew Brenner, MD - University of Texas San Antonio
Presentations:
Stereotactic Radiosurgery Combined with Immunotherapy for Recurrent Gliomas
Michael Lim
Surgically-Based Clinical Trials for GBM: Heat Shock Protein Vaccination
Orin Bloch
Stereotactic Image Guided Focused Laser Interstitial Thermal Therapy for Management of GBMs
Gavin Dunn
Intracranial Convection Enhanced Delivery (CED) of Rhenium Nanoliposomes and Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues
Andrew Brenner
For more information and to register, please visit https://www.novaliscircle.org/events/
SATURDAY, NOVEMBER 18, 2017
LUNCH-TIME ISS SESSIONS: 12:15PM – 1:15PM
Targeting EGFR in Glioblastoma: Where We’ve Been and Where We’re Going
Supported by a grant from AbbVie
Location: Yerba Buena Salons 13 - 15
Chair: David Reardon - Dana-Farber Cancer Institute
Speakers:
David Reardon, MD - Dana-Farber Cancer Institute
John H. Sampson, MD, PhD - Duke University
Andrew Lassman, MD - Columbia University
Presentations:
Molecular classification and the search for targets in GBM
John H. Sampson
Drilling down on EGFR-targeted therapy
Andrew Lassman
prIME Points™
David Reardon
For more information and to register please visit: http://www.primeoncology.org/live-education/solid-tumor/egfr-gbm-2017/
EGFR-Targeted Therapy for Leptomeningeal Carcinomatosis in Non-Small Cell Lung Cancer
Supported by a grant from AstraZeneca
Location: Nob Hill CD
Chair: Manmeet Ahluwalia, MD, FAC – Cleveland Clinic
Faculty:
Jeremy Rudnick, MD - Cedars-Sinai Medical Center
Heather Wakelee, MD - Stanford University
Manmeet Ahluwalia, MD, FAC – Cleveland Clinic
Presentations:
Leptomeningeal carcinomatosis in non-small cell lung cancer (NSCLC): The scope of the challenge
Jeremy Rudnick
Examining strategies for leptomeningeal carcinomatosis in EGFR-mutant NSCLC
Heather Wakelee
prIME Points™
Manmeet Ahluwalia
For more information and to register, visit: http://www.primeoncology.org/live-education/solid-tumor/leptomeningeal-carcinomatosis-nsclc-2017/